NecstGen announces that the Dutch constructor Kuijpers has obtained the contract for the construction of its Cell- and Gene Therapy facility. Throughout the next year, NecstGen’s facility will be constructed in Mirai House on the largest Life Science and Health hub of The Netherlands, the Leiden Bio Science Park. Kuijpers is specialised in the design and construction of cleanrooms and GMP facilities. As main contractor the company will be responsible for technical installations and construction.

“We are pleased with the collaboration with Kuijpers, and look forward to a successful construction trajectory. This brings us one step closer to realizing our mission – to bring more regenerative therapies, faster to the patient,” comments Paul Bilars, CEO of NecstGen.